Bal Pharma appoints S Anika Mercylin as CS, Compliance Officer

Published On 2018-12-29 04:15 GMT   |   Update On 2018-12-29 04:15 GMT

New Delhi: Drug major Bal Pharma recently appointed Ms S Anika Mercylin as the Company Secretary and Compliance Officer.


The company stated in a BSE filing, "as per the provisions of Section 203 of the Companies Act,2013, the Board of Directors of the Company at their meeting held has inter alia appointed Ms.S.Anika Mercylin (M.No A41933) as Company Secretary and Compliance officer of the Company."


Ms.S.Anika Mercylin, an ACS qualified has been appointed on terms as per the HR policy of the company.


Ms S Anika Mercylin has attended Institute of Company Secretaries of India. She possesses two years experience of Company Secretaryship.


The filing further added a disclosure," She is not related to any Directors or KMP's of the relationship with Directors & KMP's Company.


"As per the provisions of Regulation 30(5) of SEBI(LODR) Regulations, 2015, Ms.Anika Mercylin was also authorized by the Board for the purpose of determining the materiality of event or information and to disclose the same to the exchange within the specific period."


Bal Pharma is an Indian Pharmaceutical Company with 25 years of experience, specialized in Prescription Drugs, Generic & OTC Products, Intravenous Infusion and Bulk Actives.






Bal Pharma’s API are largely exported to Europe, the Far East, Latin America, Africa, the Middle East and other World markets. The FDF is exported to Semi-Regulated, Non-Regulated market.

Also Read: Bal Pharma commenses commercial production at Udaipur unit


Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News